The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 10, 2013, Pages 4133-4142

  Arafat, A M ^a,b   Weickert, M O ^b,c,d   Adamidou, A ^a   Otto, B ^e   Perschel, F H ^a   Spranger, J ^a   Mohlig M ^a,b   Pfeiffer, A F H ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GLUCAGON; INSULIN;

ADULT; APPETITE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIPOLYSIS; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING; SATIETY;

ADULT; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FEMALE; GHRELIN; GLUCAGON; HUMANS; MALE; OBESITY; SATIATION; SATIETY RESPONSE;

EID: 84885226494     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1635     Document Type: Article

References (31)

1. Geary N. Pancreatic glucagon signals postprandial satiety. Neurosci Biobehav Rev. 1990; 14(3): 323-338.
2. Geary N, Asarian L, Langhans W. The satiating potency of hepatic portal glucagoninrats is not affectedby[corrected] insulinorinsulin antibodies. Physiol Behav. 1997; 61(2): 199-208.
3. Geary N, Kissileff HR, Pi-Sunyer FX, Hinton V. Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. Am J Physiol. 1992; 262(6 Pt 2): R975-R980.
4. Christophe J. Glucagon and its receptor in various tissues. Ann NY Acad Sci. 1996; 805: 31-42.
5. Arafat MA, Otto B, Rochlitz H., et al Glucagon inhibits ghrelin secretion in humans. Eur J Endocrinol. 2005; 153(3): 397-402.
6. Le SJ, Geary N. Hepatic portal glucagon infusion decreases spontaneous meal size in rats. Am J Physiol. 1991; 261(1 Pt 2): R154-R161.
7. Le SJ, Noh U, Geary N. Hepatic portal infusion of glucagon anti-bodies increases spontaneous meal size in rats. Am J Physiol. 1991; 261(1 Pt 2): R162-R165.
8. Banks WA, Tschop M, Robinson S.M., Heiman ML Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther. 2002; 302(2): 822-827.
9. Lu SC, Xu J, Chinookoswong N., et al An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice. Mol Pharmacol. 2009; 75(4): 901-907.
10. Anderwald C, Brabant G, Bernroider E., et al Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes. 2003; 52(7): 1792-1798.
11. Tong Q, Ye CP, Jones J.E., Elmquist JK, Lowell BB Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat Neurosci. 2008; 11(9): 998-1000.
12. Arafat AM, Perschel FH, Otto B, et al Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level. J Clin Endocrinol Metab. 2006; 91(9): 3528-3533.
13. Arafat AM, Kaczmarek P, Skrzypski M., et al Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? Diabetologia. 2013; 56(3): 588-597.
14. Holt SH, Miller JC, Petocz P, Farmakalidis E. A satiety index of common foods. Eur J Clin Nutr. 1995; 49(9): 675-690.
15. Zhang BB, Moller DE New approaches in the treatment of type 2 diabetes. Curr Opin Chem Biol. 2000; 4(4): 461-467.
16. Brubaker PL, Drucker DJ Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels. 2002; 8(3-4): 179-188.
17. Inokuchi A, Oomura Y, Shimizu N., Yamamoto T. Central action of glucagon in rat hypothalamus. Am J Physiol. 1986; 250(1 Pt 2): R120-R126.
18. Abbott CR, Monteiro M, Small C.J., et al The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005; 1044(1): 127-131.
19. Tong J, Pfluger PT, Tschop MH Gastric O-acyl transferase activates hunger signal to the brain. Proc Natl Acad Sci USA. 2008; 105(17): 6213-6214.
20. Hosoda H, Kojima M, Matsuo H., Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000; 279(3): 909-913.
21. Yang J, Brown MS, Liang G, Grishin N.V., Goldstein JL Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008; 132(3): 387-396.
22. English PJ, Ghatei MA, Malik I.A., Bloom SR, Wilding JP Food fails to suppress ghrelin levelsinobese humans. J Clin Endocrinol Metab. 2002; 87(6): 2984.
23. Vestergaard ET, Hansen TK, Nielsen S, Moller N., Christiansen JS, Jorgensen JO Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis. Eur J Endocrinol. 2005; 153(4): 545-549.
24. Hu Z, Cha SH, van Haasteren G, Wang J, Lane MD Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects. Proc Natl Acad Sci USA. 2005; 102(11): 3972-3977.
25. Nishi Y, Hiejima H, Hosoda H., et al Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology. 2005; 146(5): 2255-2264.
26. Weickert MO, Loeffelholz CV, Arafat A.M., et al Euglycemic hyperinsulinemia differentially modulates circulating total and acylated-ghrelin in humans. J Endocrinol Invest. 2008; 31(2): 119-124.
27. Geary N, Le SJ, Noh U. Glucagon acts in the liver to control spontaneous meal size in rats. Am J Physiol. 1993; 264(1 Pt 2): R116-R122.
28. Strubbe JH, Wolsink JG, Schutte A.M., Balkan B., Prins AJ Hepaticportal and cardiac infusion of CCK-8 and glucagon induce different effects on feeding. Physiol Behav. 1989; 46(4): 643-646.
29. Jensen PB, Blume N, Mikkelsen J.D., et al Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus. J Clin Invest. 1998; 101(2): 503-510.
30. Bowen J, Noakes M, Trenerry C., Clifton PM Energy intake, ghrelin, and cholecystokinin after different carbohydrate and protein preloads in overweight men. J Clin Endocrinol Metab. 2006; 91(4): 1477-1483.
31. Cherrington AD. The metabolic actions of glucagon. In: Draznin B, Rizza E, eds. Clinical Research in Diabetes and Obesity. Volume 1: Methods, Assessment, and Metabolic Regulation (Contemporary Biomedicine). Totowa, NJ: Humana Press; 1997: 222.